Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles
Journal of Extracellular Vesicles · 2023-08 · 12 (8)
DOI: 10.1002/jev2.12352 ↗At a glance
Journal article in Journal of Extracellular Vesicles, published online on 2023-07-31. Written by Yé Fan and 8 co-authors. Institution: Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Inserm, CNRS, Paris, France. Major MEDLINE topics: Extracellular Vesicles, Tetraspanin 28, Tetraspanin 29, Tetraspanin 30. Cited 153 times so far (Crossref); 73 references. The full text is freely available (open access, CC BY 4.0). Funded by: Agence Nationale de la Recherche.
Abstract (original language)
The tetraspanins CD9, CD81 and CD63 are major components of extracellular vesicles (EVs). Yet, their impact on EV composition remains under‐investigated. In the MCF7 breast cancer cell line CD63 was as expected predominantly intracellular. In contrast CD9 and CD81 strongly colocalized at the plasma membrane, albeit with different ratios at different sites, which may explain a higher enrichment of CD81 in EVs. Absence of these tetraspanins had little impact on the EV protein composition as analysed by quantitative mass spectrometry. We also analysed the effect of concomitant knock‐out of CD9 and CD81 because these two tetraspanins play similar roles in several cellular processes and associate directly with two Ig domain proteins, CD9P‐1/EWI‐F/PTGFRN and EWI‐2/IGSF8. These were the sole proteins significantly decreased in the EVs of double CD9‐ and CD81‐deficient cells. In the case of EWI‐2, this is primarily a consequence of a decreased cell expression level. In conclusion, this study shows that CD9, CD81 and CD63, commonly used as EV protein markers, play a marginal role in determining the protein composition of EVs released by MCF7 cells and highlights a regulation of the expression level and/or trafficking of CD9P‐1 and EWI‐2 by CD9 and CD81.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Inserm, CNRS, Paris, France.
- UMS Production et Analyse des données en Sciences de la vie et en Santé, PASS, Plateforme Post-génomique de la Pitié-Salpêtrière, P3S, Sorbonne Université, Inserm, Paris, France.
- Inserm U932, Institut Curie Centre de Recherche, PSL Research University, Paris, France.
- Institut Pierre Louis d'Épidémiologie et de Santé Publique, Sorbonne Université, Inserm, Paris, France.
- CurieCoretech Extracellular Vesicles, Institut Curie Centre de Recherche, Paris, France.
- Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille Université, Inserm, CNRS, Marseille, France.
ORCID profiles: Cédric Pionneau, Federico Cocozza, Pierre-Yves Boëlle, Solenne Chardonnet, Stéphanie Charrin, Clotilde Théry, Pascale Zimmermann, Eric Rubinstein
Funding
- Agence Nationale de la Recherche
Cite
APA
Fan, Y., Pionneau, C., Cocozza, F., Boëlle, P. Y., Chardonnet, S., Charrin, S., Théry, C., Zimmermann, P., & Rubinstein, E. (2023). Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles. Journal of Extracellular Vesicles, 12(8). https://doi.org/10.1002/jev2.12352
Vancouver
Fan Y, Pionneau C, Cocozza F, Boëlle PY, Chardonnet S, Charrin S, et al. Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles. Journal of Extracellular Vesicles. 2023;12(8). doi:10.1002/jev2.12352
BibTeX
@article{Fan2023,
author = {Fan, Yé and Pionneau, Cédric and Cocozza, Federico and Boëlle, Pierre-Yves and Chardonnet, Solenne and Charrin, Stéphanie and Théry, Clotilde and Zimmermann, Pascale and Rubinstein, Eric},
title = {Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles},
journal = {Journal of Extracellular Vesicles},
year = {2023},
volume = {12},
number = {8},
doi = {10.1002/jev2.12352}
}
EUVIMED